Stocks in Play
8/5/2022 - 11:50 AM EST - InnoCan Pharma : Announces that it has filed a new patent application entitled 'compositions for treatment of hair loss', claiming priority from an earlier US provisional patent application. The composition developed by Innocan research and development and disclosed in the current PCT can be used to treat and prevent hair loss and is applied topically to the skin or scalp. This application contributes to Innocan's continued expansion of its health and wellness intellectual property portfolio of 14 patent families. InnoCan Pharma shares C.INNO are trading unchanged at $0.48.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.